Home    Back

Allogeneic adipose tissue-derived mesenchymal stem cells    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
97Ulcerative colitis1

97. Ulcerative colitis    [ 2,269 clinical trials,   1,331 drugs,   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways]
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,269 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01914887
(ClinicalTrials.gov)		June 201318/7/2013Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative ColitisA Phase I/IIa Clinical Trial to Evaluate Safety and Efficacy of Adipose Tissue-derived Mesenchymal Stem Cells (ASC) on Induction to Remission in Ulcerative ColitisUlcerative ColitisDrug: Allogeneic adipose tissue-derived mesenchymal stem cellsInstituto de Investigación Hospital Universitario La PazFundacion para la Investigacion Biomedica del Hospital Universitario la Paz;Ministry of Health, SpainRecruiting18 YearsN/ABoth8Phase 1;Phase 2Spain